Embed
Email

Estrogen in 2010

Document Sample

Shared by: changcheng2
Categories
Tags
Stats
views:
5
posted:
11/6/2011
language:
English
pages:
28
Dr Dedeshya Holowenko

 none

 Indications for estrogen therapy

 Risks of estrogen therapy

 Transdermal vs oral estrogen

 Atrophic vaginitis

◦ very common in the post menopausal woman

◦ Causes decreased libido, urinary irritability,

dysparenia and relationship discord



 Natural Menopause

◦ Peri and early post menopause (65 years

Coronary Events with HT

Younger Vs. Older Women



Less than 60 years old

 Decreased risk CHD by 30%

 OR 0.68 (0.48 – 0.95)



Greater than 60 years old

 First year increased risk CHD

 OR 1.47 (1.12 – 1.92)



 2nd year decreased risk of CHD

by 20%

 OR 0.79 (0.67 – 0.93)



Salpeter, JGIM 2006; 21:363-366

Coronary Events with HT

Younger Vs. Older Women



Take Home Message:



“Hormone Therapy reduces the risk

(protects) of CHD events in younger

postmenopausal women. In older

women HT increases, then decreases

risk over time”









Salpeter, JGIM 2006; 21:363-366

 Consider transdermal estrogen

 Oral estrogens have a higher risk of

thromboembolic events than transdermal

estrogen

Oral Therapy

Tablet must pass through

the digestive system and

liver before reaching

circulation









Transdermal therapy

Hormone has immediate access to

the circulation without concerns for

the liver and digestion

 Oral estrogens can induce

the production of numerous

hepatic proteins, such as:

◦ angiotensinogen

◦ sex-hormone-binding globulin

◦ Increased clotting factors



 High estrogen concentrations

in the liver increases metabolic burden

◦ increases biologically active metabolites



 Impaired hepatic function can lead to

hyperestrogenism

◦ may have substantial estrogenic side effects









Mueck AO: Münchner Medizinische Wochenschrift 1997; 139:495–9.

• Smoking reduces endogenous

estrogen levels



• Nicotine may increase hepatic

metabolism of estrogen via CYP 450

enzymes



• Smoking increases SHBG



• Consider transdermal delivery to

avoid first-pass liver metabolism (if

they are already on an estrogen)





Lobo, JRM 37:77,1992

Can. Cons. Men. Osteo. JSOGC:20, 1998

 Oral Transdermal



 Decreased libido x 

 High TG w/ caution 

 Hypertension w/ caution 

 Smokers w/ caution 

 Post thromboembolism x ?



Thyroid disorders w/ caution 

Disorders of the liver w/ caution 

Disorders of the gall bladder w/ caution 

 Disorders of the pancreas w/ caution 

Disorders of the stomach or intestine w/ caution 



Mueck AO: Münchner Medizinische Wochenschrift 1997; 139:495–9.

FDA approved Bioidentical Hormones



Related docs
Other docs by changcheng2
Trust Meeting Dates for 2010
Views: 0  |  Downloads: 0
Puer Nobis Nascitur
Views: 0  |  Downloads: 0
Newsletter 7th Edition
Views: 0  |  Downloads: 0
Euro Vin Inventory20080802
Views: 0  |  Downloads: 0
llethi
Views: 0  |  Downloads: 0
newsnow dummy
Views: 2  |  Downloads: 0
229315-upload-00001
Views: 0  |  Downloads: 0
amyot
Views: 2  |  Downloads: 0
By registering with docstoc.com you agree to our
privacy policy

You are almost ready to download!

You are almost ready to download!